First SGLT1/2 inhibitor shows ‘spectacular’ phase 3 safety and efficacy in T2DNovember 18, 2020DiabetesCardiology
Lancet panel calls for urgent global action to combat diabetesNovember 13, 2020DiabetesBusiness of Medicine
New guidelines address diabetes management in kidney diseaseNovember 13, 2020DiabetesEndocrinologyNephrology
Don’t miss cardiovascular risk factors in transgender patientsNovember 13, 2020DiabetesTransgender HealthPreventive CareCardiologyEndocrinology
Medication adherence challenges and helpersNovember 6, 2020Business of MedicinePreventive CarePulmonologyAsthmaWomen's HealthDiabetesEndocrinology
First-of-its kind guideline on lipid monitoring in endocrine diseasesNovember 6, 2020DiabetesMen's HealthEndocrinology
Novel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesNephrologyCardiologyMixed Topics
